Comparing ways to prevent, detect early, and treat lung cancer
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions
Computer models compare tobacco control, screening, and new treatments to find which strategies could best lower lung cancer for people who smoke or are at higher risk.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Provincial Health Services Authority NIH-funded |
| Lab location | 1 site (Vancouver, Canada) |
| Project ID | NIH-10927292 on NIH RePORTER |
What this research studies
From my perspective, researchers use large-scale computer models and national data to simulate how different tobacco control policies, screening programs, early detection methods, and treatment advances might change lung cancer cases and deaths. The work includes concerns about new products like e-cigarettes and looks at how prevention, early detection, and treatment could work together. This project uses existing public-health and clinical datasets rather than enrolling people in a clinical trial. Findings are meant to help guide policies and medical guidelines that affect people at risk for lung cancer.
Who could benefit from this research
Good fit: People who currently smoke, former smokers, and others at higher risk of lung cancer (for example older adults with a history of smoking) are the main groups who could benefit from the results.
Not a fit: People at very low risk for lung cancer, such as young never-smokers, are unlikely to see direct benefits from this modeling work.
Why it matters
Potential benefit: If successful, this could help shape policies and screening guidelines that reduce lung cancer deaths and improve early detection for people at risk.
How similar studies have performed: Previous CISNET modeling has successfully informed U.S. tobacco-control and lung cancer screening recommendations, so this project builds on established, influential modeling efforts.
Where this research is happening
Vancouver, Canada
- Provincial Health Services Authority — Vancouver, Canada (Active)
Researchers
- Principal investigator: Meza, Rafael — Provincial Health Services Authority
- Study coordinator: Meza, Rafael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.